An Examination of Long‐Term Abnormal Stock Returns and Operating Performance Following R&D Increases

ABSTRACT We examine a sample of 8,313 cases, between 1951 and 2001, where firms unexpectedly increase their research and development (R&D) expenditures by a significant amount. We find consistent evidence of a misreaction, as manifested in the significantly positive abnormal stock returns that our s... View More